HIGH

Medtronic MiniMed 620G Insulin Pump Recall Impacts 799 Units Worldwide (2026)

Medtronic MiniMed recalled 799 infusion pumps worldwide, including in the United States. The devices in the Paradigm, 600, and BLE 700 series can deliver too much or too little insulin when their height relative to the infusion site changes due to gravity. Stop using the pump immediately and contact Medtronic MiniMed for instructions on replacement or refund.

Quick Facts at a Glance

Recall Date
February 13, 2026
Hazard Level
HIGH
Brand
Medtronic MiniMed
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

Hazard Information

All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Medtronic MiniMed, Inc. or your healthcare provider for instructions. Notification method: Letter

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

About This Product

Medtronic MiniMed insulin pumps automate or assist insulin delivery for diabetes management. The 620G is part of older Paradigm/600 BLE lines and may connect with continuous glucose monitoring systems.

Why This Is Dangerous

The device's height relative to the infusion site affects hydrostatic and hydrodynamic pressures, causing potential insulin over-delivery or under-delivery.

Industry Context

This recall is not presented as part of a broader industry pattern in the provided data.

Real-World Impact

Patients may experience severe hypo- or hyperglycemia, requiring urgent medical care. The recall affects 799 units across a wide distribution network worldwide.

Practical Guidance

How to identify if yours is affected

  1. Check model numbers on device label and user manual
  2. Look up UDI-DI on packaging or device label
  3. Review recall notices for affected series (Paradigm, 600, BLE 700)
  4. Record date codes and serial numbers if available

Where to find product info

Device labels, user manuals, recall notices, FDA enforcement page

What timeline to expect

Refunds or replacements typically take 4-8 weeks after submission

If the manufacturer is unresponsive

  • Escalate to FDA recall complaint channels
  • Keep a detailed log of contacts
  • Seek legal advice if delays are prolonged

How to prevent similar issues

  • Register for recall alerts from Medtronic and FDA
  • Verify device status before use or replacement
  • Ask healthcare providers about newer pump models with updated safety features
  • Monitor for recall updates on official sites

Documentation advice

Keep all recall notices, device serial numbers, photos of labels, receipts, and all correspondence with Medtronic.

Product Details

Model numbers and devices affected include MiniMed 620G insulin pump and related Paradigm, 600, and BLE 700 series pumps. Distribution is worldwide, including US states and many countries.

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • 799 units recalled
  • Worldwide distribution
  • High hazard level
  • Recall date 2026-02-13

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
9/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Details

Model Numbers
MiniMed 620G Insulin Pump
Paradigm series
600 series
BLE 700 series
Affected States
ALL
Report Date
April 8, 2026
Recall Status
ACTIVE

Related Recalls

Vehicles & Parts
HIGH

Mazda CX-70 Recall 2025 for Powertrain Control Module Software May Lose Drive Power

Mazda North American Operations is recalling 2024 CX-90 and 2025 CX-70 SUVs sold through Mazda dealers. The PCM and ECM software can illuminate malfunction indicator lights and cause a loss of drive power, increasing crash risk. Owner notification letters were mailed December 19, 2024, and Mazda will reprogram the PCM and ECM at no charge.

Mazda
Loss of
Read more
Vehicles & Parts
HIGH

Nissan Kicks 2025 Certification Label Recall for GVWR/GAWR Errors (PD136, PMA47)

Nissan North America is recalling certain 2025 Nissan Kicks vehicles sold through Nissan dealers nationwide. The certification label may print incorrect GVWR and GAWR values, risking overload. Some SR trims with a 19-inch wheel package may display an incorrect wheel size on the label, and owners should contact their Nissan dealer to arrange replacement labels.

Nissan
An overloaded
Read more